DE LUCA, Michele
 Distribuzione geografica
Continente #
NA - Nord America 19.138
EU - Europa 10.255
AS - Asia 9.609
SA - Sud America 1.217
AF - Africa 173
OC - Oceania 71
Continente sconosciuto - Info sul continente non disponibili 16
Totale 40.479
Nazione #
US - Stati Uniti d'America 18.860
GB - Regno Unito 4.078
SG - Singapore 2.768
CN - Cina 2.675
IT - Italia 2.212
HK - Hong Kong 1.362
BR - Brasile 949
SE - Svezia 857
VN - Vietnam 835
DE - Germania 626
FI - Finlandia 480
UA - Ucraina 455
BD - Bangladesh 372
TR - Turchia 366
FR - Francia 356
RU - Federazione Russa 319
KR - Corea 293
IN - India 195
BG - Bulgaria 168
SI - Slovenia 166
CA - Canada 164
JP - Giappone 135
ID - Indonesia 127
NL - Olanda 125
AR - Argentina 85
PL - Polonia 72
MX - Messico 67
IQ - Iraq 65
ZA - Sudafrica 62
AE - Emirati Arabi Uniti 51
ES - Italia 50
IE - Irlanda 49
PK - Pakistan 49
EC - Ecuador 45
BE - Belgio 40
IR - Iran 39
CL - Cile 38
AU - Australia 37
CO - Colombia 37
AT - Austria 36
NZ - Nuova Zelanda 34
UZ - Uzbekistan 33
PH - Filippine 30
SA - Arabia Saudita 30
TW - Taiwan 30
CZ - Repubblica Ceca 27
LT - Lituania 27
MA - Marocco 26
MY - Malesia 23
EG - Egitto 22
VE - Venezuela 22
DK - Danimarca 20
RO - Romania 19
TH - Thailandia 17
DZ - Algeria 16
JO - Giordania 14
QA - Qatar 14
KE - Kenya 13
TN - Tunisia 13
CH - Svizzera 12
PT - Portogallo 12
PY - Paraguay 12
UY - Uruguay 12
IL - Israele 11
KZ - Kazakistan 11
NP - Nepal 11
PE - Perù 11
EU - Europa 9
AZ - Azerbaigian 8
AL - Albania 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
BY - Bielorussia 6
ET - Etiopia 6
HU - Ungheria 6
KW - Kuwait 6
NI - Nicaragua 6
PS - Palestinian Territory 6
RS - Serbia 6
CR - Costa Rica 5
MD - Moldavia 5
OM - Oman 5
SV - El Salvador 5
GR - Grecia 4
GT - Guatemala 4
HN - Honduras 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
BO - Bolivia 3
CG - Congo 3
KH - Cambogia 3
LB - Libano 3
LV - Lettonia 3
MN - Mongolia 3
PA - Panama 3
XK - ???statistics.table.value.countryCode.XK??? 3
BZ - Belize 2
Totale 40.444
Città #
Southend 3.199
Santa Clara 1.848
Ashburn 1.697
Singapore 1.615
Fairfield 1.552
Hong Kong 1.336
Woodbridge 1.321
Chandler 1.029
Houston 999
Jacksonville 961
San Jose 835
Hefei 772
Dearborn 694
Ann Arbor 620
Wilmington 577
Cambridge 561
Seattle 552
Beijing 485
London 438
Nyköping 385
Los Angeles 336
Helsinki 309
The Dalles 279
Council Bluffs 275
Seoul 253
Ho Chi Minh City 249
Hanoi 214
Modena 213
Milan 212
San Diego 183
Chicago 181
Izmir 180
New York 180
Princeton 180
Sofia 166
Eugene 151
Lauterbourg 140
Rome 132
Des Moines 125
Buffalo 115
Bologna 105
Bari 101
Columbus 101
Moscow 96
Shanghai 89
Jakarta 86
São Paulo 83
Redwood City 82
Falls Church 81
Munich 78
Salt Lake City 69
Dallas 67
Tokyo 65
Boardman 56
Orem 50
Frankfurt am Main 46
Norwalk 45
Phoenix 43
Warsaw 40
Bremen 39
Dublin 38
Guangzhou 37
Haiphong 36
Toronto 34
Brooklyn 33
Kent 32
Atlanta 31
Tampa 31
Elk Grove Village 30
Auckland 28
Brasília 28
Changsha 28
Da Nang 28
Xi'an 28
Belo Horizonte 27
Brussels 27
Chennai 27
Nanjing 27
Rio de Janeiro 27
Tashkent 27
Formigine 26
Montreal 26
Paris 26
Baghdad 25
Denver 25
Miano 25
Reggio Emilia 25
Falkenstein 24
Glasgow 24
Johannesburg 23
Naples 23
Amsterdam 22
Campinas 22
Catania 22
Dhaka 22
Mexico City 22
Kunming 21
Medesano 21
Turku 21
Quito 20
Totale 28.040
Nome #
Regeneration of the entire human epidermis using transgenic stem cells 862
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 578
Holoclar: first of its kind in more ways than one 534
Applicazioni cliniche dei cheratinociti umani normali coltivati in vitro 479
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 430
Comparative assessment of cultures from oral and urethral stem cells for urethral regeneration 423
Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides 415
Concise review: hurdles in a successful example of limbal stem cell-based regenerative medicine 392
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 381
Laminin 332-Dependent YAP Dysregulation Depletes Epidermal Stem Cells in Junctional Epidermolysis Bullosa 381
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 376
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 372
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 368
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 359
Advances in Gene/Cell Therapy in Epidermolysis Bullosa 356
Polarized expression of integrin receptors (a6b4, a2b1, a3b1, avb5) and their relationshipwith the cytoskeleton and basement membrane matrix in cultured human keratinocytes. [5YIF: 10.77; Citations: 127] 348
A volume-sensitive chloride conductance revealed in cultured human keratinocytes by 36Cl- efflux and whole-cell patch clamp recording 347
Advances in stem cell research and therapeutic development 345
Ultrasensitive in vivo bioassay detects bioactive human growth hormone in transduced primary human keratinocytes 340
Gentamicin induces LAMB3 nonsense mutation readthrough and restores functional laminin 332 in junctional epidermolysis bullosa 335
Autologous fibrin-cultured limbal stem cells permanently restore the corneal surface of patients with total limbal stem cell deficiency 328
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 321
"HepG2/erythroid/brain" type glucose transporter (GLUT1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis 318
Q-FIHC: Quantification of fluorescence immunohistochemistry to analyse p63 isoforms and cell cycle phases in human limbal stem cells 311
Navigating Market Authorization: The Path Holoclar Took to Become the First Stem Cell Product Approved in the European Union 307
The control of epidermal stem cells (holoclones) in the treatment of massive full-thickness burns with autologous keratinocytes cultured on fibrin. [5YIF: 3.60, Citations: 215] 306
Separation of keratan-sulfate-derived disaccharides by high-performance liquid chromatography and postcolumn derivatization with 2-cyanoacetamide and fluorimetric detection 304
Methods for characterization/manipulation of human corneal stem cells and their applications in regenerative medicine. 303
The long and winding road that leads to a cure for epidermolysis bullosa 303
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 302
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 298
A two-stage, p16INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status 297
Inherited epidermolysis bullosa: description of clinical and subclinical morphological features with optical coherence tomography 296
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 295
Human epithelial cells induce human melanocyte growth in vitro but only skin keratinocytes regulate its proper differentiation in the absence of dermis. 295
Chloride transport pathways in human keratinocytes 294
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 294
Allele specific CRISPR/Cas9 editing of dominant Epidermolysis Bullosa Simplex in human epidermal stem cells 291
Gene therapy approaches for epidermolysis bullosa 291
Clonal analysis of human clonogenic keratinocytes 288
AMPLICON-BASED NGS: AN EFFECTIVE APPROACH FOR THE MOLECULAR DIAGNOSIS OF EPIDERMOLYSIS BULLOSA 283
Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa 282
A discussion on cell therapy in Manchester 277
Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors 276
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia 276
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 273
Role of integrins in cell adhesion and polarity in normal keratinocytes and human skin pathologies 268
In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors 268
Corrective transduction of human epidermal stem cells in laminin-5-dependent Junctional Epidermolysis Bullosa. 267
Corneal Bioengineering 266
Regulation of stem cell therapies under attack in Europe: for whom the bell tolls 266
p63 identifies keratinocyte stem cells 265
Stem cell plasticity: time for a reappraisal? 264
Cell biology: Dormant and restless skin stem cells 262
Eyes on the prize: Limbal stem cells and corneal restoration 260
Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. 258
Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis 256
Gene therapy of inherited skin adhesion disorders: a critical overview 255
Characterization of chloride transport pathways in cultured human keratinocytes 255
HIV-1 spreads from lymphocytes to normal human keratinocytes suitable for autologous and allogenic transplantation 255
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1 252
Treatment of 'stable' vitiligo by Timedsurgery transplantation of cultured epidermal autografts 252
A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis 250
Topography and biological role of integrins in human skin 249
Expression of VSX1 in human corneal keratocytes during differentiation into myofibroblasts in response to wound healing 247
Telomerase activity is sufficient to bypass replicative senescence in human limbal and conjunctival but not corneal keratinocytes 247
Analysis of the mechanical properties of in vitro reconstructed epidermis: preliminary results 245
Psoriatic lesions in patients with chronic liver disease are distinct from psoriasis vulgaris lesions, as judged on basis of integrin adhesion receptors 245
Towards a gene therapy clinical trial for epidermolysis bullosa 244
Limbal stem-cell therapy and long-term corneal regeneration. 244
The importance of epidermal stem cells in keratinocyte-mediated gene therapy 242
Stamina therapies: Let the record stand 241
Regeneration of squamous epithelia from stem cells of cultured grafts 238
Advances on potential therapeutic options for epidermolysis bullosa 236
High expression levels of the "erythroid/brain" type glucose transporter (GLUT1) in the basal cells of human eye conjunctiva and oral mucosa reconstituted in culture 235
The Ocular Albinism type 1 gene product is a membrane glycoprotein localized to melanosomes. 235
Expression of integrin receptors and their role in adhesion, spreading and migration of normal human melanocytes 234
Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo. 233
Ocular Albinism: evidence for a defect in an intracellular signal transduction system. 232
[Inhibition of the biosynthesis of thyroglobulin with propranolol in the rat] 232
Towards therapeutic application of ocular stem cells 230
Effective retrovirus-mediated gene transfer in normal and mutant human melanocytes 228
Structural and functional studies of integrin receptors in cultured human keratinocytes 228
Stairways to Advanced Therapies for Epidermolysis Bullosa 227
Clonal analysis of stably transduced human epidermal stem cells in culture. 226
Treatment of leg ulcers with cryopreserved allogeneic cultured epithelium. A multicenter study 225
Isoforms of ΔNp63 and the migration of ocular limbal cells in human corneal regeneration 225
[Inhibition of the biosynthesis of thyroglobulin in the thyroid gland of rats by isoniazid] 220
Expression, topography and function of integrin receptors is severely altered in keratinocytes from involved and uninvolved psoriatic skin. 219
Cultivation of human keratinocyte stem cells: current and future clinical applications 219
Toward gene therapy of junctional epidermolysis bullosa (JEB) 218
CRYOPROTECTIVE AQUEOUS SOLUTIONS USEFUL FOR THE PRESERVATION OF IN VlTRO CULTURED EPITHELIAL SHEETS 218
Permanent coverage of full skin thickness burns with autologous cultured epidermis and reepithelialization of partial skin thickness lesions induced by allogeneic cultured epidermis: a multicentre study in the treatment of children 216
Transforming Growth-Factor-Beta-1 Modulates Beta-1 And Beta-5 Integrin Receptors And Induces The De-Novo Expression Of The Alpha-V-Beta-6 Heterodimer In Normal Human Keratinocytes - Implications For Wound-Healing. 216
sAPP as a regulator of dendritic motility and melanin release in epidermal melanocytes and melanoma cells. 215
Biochemical role of FOXM1-dependent histone linker H1B in human epidermal stem cells 211
Downregulation of 14-3-3σ prevents clonal evolution and leads to immortalization of primary human keratinocytes 211
Culture of human epithelium 209
A multicenter experience in the treatment of burns with autologous and allogeneic cultured epithelium fresh or preserved in a frozen state 209
Treatment of posterior hypospadias by the autologous graft of cultured urethral epithelium. 209
Totale 29.007
Categoria #
all - tutte 148.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.021


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 0 0 0 0 0 179
2021/20223.170 79 403 238 284 141 250 202 173 345 218 471 366
2022/20233.174 369 339 333 233 365 475 69 285 424 43 140 99
2023/20242.028 76 128 123 159 387 128 119 271 55 225 83 274
2024/20257.304 254 98 175 478 1.276 1.146 570 379 683 271 913 1.061
2025/202611.722 759 658 983 1.073 1.231 941 1.540 624 1.182 1.183 762 786
Totale 40.824